BlackRock’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.93M | Sell |
1,368,005
-3,071,260
| -69% | -$6.57M | ﹤0.01% | 3887 |
|
|
2025
Q1 | $5.11M | Sell |
4,439,265
-62,457
| -1% | -$71.8K | ﹤0.01% | 3597 |
|
|
2024
Q4 | $9.86M | Sell |
4,501,722
-409,675
| -8% | -$897K | ﹤0.01% | 3395 |
|
|
2024
Q3 | $10.7M | Buy |
4,911,397
+139,740
| +3% | +$305K | ﹤0.01% | 3323 |
|
|
2024
Q2 | $11M | Buy |
4,771,657
+1,024,564
| +27% | +$2.37M | ﹤0.01% | 3287 |
|
|
2024
Q1 | $20.6M | Sell |
3,747,093
-67,438
| -2% | -$371K | ﹤0.01% | 2930 |
|
|
2023
Q4 | $9.42M | Buy |
3,814,531
+186,311
| +5% | +$460K | ﹤0.01% | 3356 |
|
|
2023
Q3 | $126M | Buy |
3,628,220
+401,648
| +12% | +$13.9M | ﹤0.01% | 1839 |
|
|
2023
Q2 | $106M | Buy |
3,226,572
+1,177,971
| +58% | +$38.6M | ﹤0.01% | 1988 |
|
|
2023
Q1 | $68.6M | Buy |
2,048,601
+78,738
| +4% | +$2.64M | ﹤0.01% | 2222 |
|
|
2022
Q4 | $64.6M | Buy |
1,969,863
+588,360
| +43% | +$19.3M | ﹤0.01% | 2266 |
|
|
2022
Q3 | $48.2M | Buy |
1,381,503
+324,314
| +31% | +$11.3M | ﹤0.01% | 2434 |
|
|
2022
Q2 | $12.9M | Buy |
1,057,189
+565,853
| +115% | +$6.92M | ﹤0.01% | 3296 |
|
|
2022
Q1 | $6.67M | Sell |
491,336
-3,366
| -0.7% | -$45.7K | ﹤0.01% | 3718 |
|
|
2021
Q4 | $9.83M | Buy |
+494,702
| New | +$9.83M | ﹤0.01% | 3621 |
|